T Cell News and Research

Latest T Cell News and Research

XTANDI now accepted for use within NHS Scotland for treatment of adult men with mCRPC

The Scottish Medicines Consortium, which advises NHS Scotland on prescribing new treatments, announced today that XTANDI (enzalutamide) is accepted for unrestricted use within NHS Scotland for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.

13 Nov 2013

Researchers shed light on how and when immune system forms

Researchers at Lund University have shed light on how and when the immune system is formed, raising hope of better understanding various diseases in children, such as leukaemia.

13 Nov 2013

Life events influence genes important for memory and drug use

New human and animal research released today demonstrates how experiences impact genes that influence behavior and health. Today's studies, presented at Neuroscience 2013, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health, provide new insights into how experience might produce long-term brain changes in behaviors like drug addiction and memory formation.

13 Nov 2013

Infection prevention: an interview with Dr. Robert Gorab, Chief Medical Officer, Hoag Orthopedic Institute

HOI has one of the lowest if not the lowest surgical readmission rate in the State of California. Our all-cause readmission rate is 3.3% and our joint replacement readmission was at 1.8% based on published CMS reports we received in September 2013.

12 Nov 2013

Promethera Biosciences completes patient enrolment for first clinical trial of HepaStem

Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and Urea Cycle Disorders, announces today the completion of patient enrolment for its first clinical trial.

12 Nov 2013

Porvair Sciences launches multi-format mixer for laboratory use

Porvair Sciences has introduced the Co-Mix - an accurate, reliable, compact and simple-to-use multi-format mixer.

From Porvair Sciences Limited 12 Nov 2013

Cellectricon introduces Dynaflow Resolve Temperature Control system for ion channel research

Cellectricon, a leading provider of advanced cell-based screening technologies and services, launches the Dynaflow Resolve Temperature Control system at Neuroscience 2013 (San Diego), booth #933.

From Cellectricon 12 Nov 2013

Revalesio to conduct RNS60 Phase IIa clinical trial in RRMS patients

Revalesio Corporation is pleased to announce a new collaboration with noted neurologist Dr. Roland Martin, Head of Neuroimmunology and MS Research at the Department of Neurology, University Hospital Zurich. Dr. Martin will be conducting a Phase IIa clinical trial of RNS60 in patients with relapsing-remitting multiple sclerosis.

12 Nov 2013

Study provides new evidence underlining the significance of bitter taste perception

It's no coincidence that the expression "to leave a bitter taste in one's mouth" has a double meaning; people often have strong negative reactions to bitter substances, which, though found in healthful foods like vegetables, can also signify toxicity. For this reason, the ability to sense bitterness likely played an important role in human evolution.

12 Nov 2013

Australian scientists unravel mystery behind immune system memory

While the principle of immune memory has been known for decades, the exact molecular mechanisms underpinning it have remained a mystery. Australian scientists have now unraveled part of that mystery, identifying the role of a gene called STAT3, which acts as a kind of roundabout, directing chemical messenger molecules to various destinations.

12 Nov 2013

Researchers discover new pathway for treating allergic diseases

A collaboration among researchers in Israel and the United States has resulted in the discovery of a new pathway that has broad implications for treating allergic diseases - particularly eosinophil-associated disorders.

12 Nov 2013

Study: Hospitals vary in management of children with traumatic brain injury

Hospitals vary in management of children with traumatic brain injury—particularly in monitoring and preventing the harmful effects of increased intracranial pressure (ICP), according to a study in the November issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

12 Nov 2013

Researchers discovers key genetic culprit responsible for growth, metastasis of colon cancer

Chronic inflammation has long been known as a key risk factor for cancer---particularly colon cancer---but the exact mechanisms of how inflammation heightens the immune response, and ultimately influences the initiation and progression of cancer have remained elusive.

12 Nov 2013

Broom offers tips to help children cope with parent's deployment

While in the Navy, Broom regularly saw children of deployed parents in military pediatric offices. His biggest take away message from that experience is that families who are most successful at navigating deployment are those who plan and communicate.

12 Nov 2013

Researchers identify critical mechanism to improve survival and behavior of new brain cells

A specialized type of brain cell that tamps down stem cell activity ironically, perhaps, encourages the survival of the stem cells' progeny, Johns Hopkins researchers report.

11 Nov 2013

INTEGRA launches new PIPETBOY acu 2 serological pipettor

Building upon over 30 years of unmatched quality and hundreds of thousands of instruments in use worldwide - INTEGRA announces the launch of the new PIPETBOY acu 2 serological pipettor.

From INTEGRA Biosciences 11 Nov 2013

Generating an alternative to IVIG therapy: an interview with Professor Richard Pleass, LSTM

IVIG is a hugely successful biological with FDA approval for treating idiopathic thrombocytopenic purpura (ITP), Kawasaki disease, Guillain-Barré syndrome, Graves ophthalmopathy and numerous polyneuropathies.

11 Nov 2013

Experts join forces to address the future of stem cell research in Australia

Australian stem cell experts are joining forces to address the future of stem cell research in Australia and the critical gap in taking innovative stem cell therapies to patients.

11 Nov 2013

GW Pharmaceuticals starts Phase 1b/2a clinical trial for Recurrent Glioblastoma Multiforme

GW Pharmaceuticals plc a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today it has commenced a Phase 1b/2a clinical trial for the treatment of Recurrent Glioblastoma Multiforme.

11 Nov 2013

CTCA doctor presents cutting-edge treatments for cancer patients to medical colleagues

Walter Quan, Jr., MD Chief of Medical Oncology and Director of Immunotherapy at Cancer Treatment Centers of America- Western Regional Medical Center is presenting new findings that are showing a major benefit to cancer patients.

11 Nov 2013

T Cell News and Research

Latest T Cell News and Research

XTANDI now accepted for use within NHS Scotland for treatment of adult men with mCRPC

Researchers shed light on how and when immune system forms

Life events influence genes important for memory and drug use

Infection prevention: an interview with Dr. Robert Gorab, Chief Medical Officer, Hoag Orthopedic Institute

Promethera Biosciences completes patient enrolment for first clinical trial of HepaStem

Porvair Sciences launches multi-format mixer for laboratory use

Cellectricon introduces Dynaflow Resolve Temperature Control system for ion channel research

Revalesio to conduct RNS60 Phase IIa clinical trial in RRMS patients

Study provides new evidence underlining the significance of bitter taste perception

Australian scientists unravel mystery behind immune system memory

Researchers discover new pathway for treating allergic diseases

Study: Hospitals vary in management of children with traumatic brain injury

Researchers discovers key genetic culprit responsible for growth, metastasis of colon cancer

Broom offers tips to help children cope with parent's deployment

Researchers identify critical mechanism to improve survival and behavior of new brain cells

INTEGRA launches new PIPETBOY acu 2 serological pipettor

Generating an alternative to IVIG therapy: an interview with Professor Richard Pleass, LSTM

Experts join forces to address the future of stem cell research in Australia

GW Pharmaceuticals starts Phase 1b/2a clinical trial for Recurrent Glioblastoma Multiforme

CTCA doctor presents cutting-edge treatments for cancer patients to medical colleagues

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in